Research shows that women who are infected with HPV have a tendency to develop cervical cancer. The purpose of this study is to see if the vaccine is safe and well tolerated. A quadrivalent HPV vaccine will be compared to an inactive substance. This vaccine has not yet been approved by the FDA for the general public, but only for research study. Procedures Study participants will be asked to visit the study clinic up to 10 times over a period of up to 3 years.
Some visits require pelvic exams, pap smears, blood draws, urine specimens, and etc.
Study participants will be asked to receive a total of 3 injections in the muscle of their arm or thigh during the first 6 months of the study. Study participants will be asked to complete history forms, questionnaires, and vaccination report cards.